Journal of Hematological Malignancies
https://www.sciedu.ca/journal/index.php/jhm
<img style="float: right; padding: 10px;" title="http://www.sciedu.ca/journal/public/site/images/jhm/homepageimage_en_us_407" src="/journal/public/site/images/jhm/homepageimage_en_us_407.jpg" alt="http://www.sciedu.ca/journal/public/site/images/jhm/homepageimage_en_us_407" width="312" height="407" /><p><strong>>> The journal is under re-structure, and will not accept new submissions. Thanks. </strong></p><p><span style="font-size: 10px;">Journal of Hematological Malignancies (ISSN 1925-4024, EISSN 1925-4032) is an open access international scientific journal providing a forum for peer-reviewed articles, reviews or commentary related to all aspects of the prevention, diagnosis and management of malignancies of the blood system, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology, and randomized controlled trials and evidence-based meta-analysis or pooled analysis related to specific trials.</span></p><p>JHM is included in:</p><ul><li>EBSCOhost</li><li>Gale's Academic Databases</li><li>Google Scholar</li><li>Lockss</li><li>PKP Open Archives Harvester</li><li>ProQuest</li><li>The Standard Periodical Directory</li></ul><p><span style="font-size: 10px;">To facilitate rapid publication and minimize administrative costs, JHM accepts <span>submissions </span><a href="/journal/index.php/jhm/about/submissions">online</a><span> or by e-mail (<a href="mailto:%6a%68%6d@%73%63%69%65%64%75%70%72%65%73%73.%63%6f%6d">jhm@sciedupress.com</a></span><span>).</span></span><span style="font-size: 10px;"> For online submission, please register and then follow the instructions given.</span></p><p>JHM’s Section:<br />Original Research, Case Report, Conference Report, Reviews.</p><p>---------------------------------------------------------------------</p><p> </p>Sciedu Pressen-USJournal of Hematological Malignancies1925-4024Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. The Editors reserve the right to edit or otherwise alter all contributions, but authors will receive proofs for approval before publication. <br />Copyrights for articles published in our journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.Acute Monocytic Leukemia Linked to Pulmonary Infiltrates and the Importance of Early Induction Chemotherapy
https://www.sciedu.ca/journal/index.php/jhm/article/view/13151
<p>Currently there is no consensus on the approach to evaluating lung infiltrates in patients with newly diagnosed acute myeloid leukemia (AML), a rare disease with an incidence of 3-4 cases per 100,000 people. The CT findings of pulmonary infiltrates in patients with AML are nonspecific and can range from confluent air-space opacities with patchy consolidation to interstitial markings and multiple subpleural small nodules. Biopsy will most often reveal bacterial or fungal infection and rarely malignant infiltrates. Here is a case of a patient with newly diagnosed AML, specifically of the monoblastic subtype, who was admitted to the hospital for induction chemotherapy and underwent transthoracic lung biopsy that confirmed monoblastic leukemic infiltrates. Following chemotherapy there was complete resolution of the lung infiltrates.</p>Yvonne ChuUmit TapanAdam Lerner
Copyright (c) 2018 Journal of Hematological Malignancies
2018-06-092018-06-0941110.5430/jhm.v4n1p1